Jonathan Young
Chief Operating Officer · Akero Therapeutics, Inc.
- 2024
- Dec 9, 2025
- 13
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Jonathan Young. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Cheng - $13.35M in AKRO purchases and sales on record
- Catriona Yale - $2.80M in AKRO purchases and sales on record
- Timothy Rolph - $2.67M in AKRO purchases and sales on record
- Patrick Lamy - $163K in AKRO purchases and sales on record
- Jane Henderson - $142K in AKRO purchases and sales on record
- William Richard White - $115K in AKRO purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Young?
Jonathan Young is a corporate insider, tracked as Chief Operating Officer of Akero Therapeutics, Inc. (AKRO). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jonathan Young last file a Form 4?
The most recent primary Form 4 on record is dated 9 December 2025, one of 13 filings going back to 2024.
Has Jonathan Young been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($5.28M) across all tracked filings.
